Solcitinib is an orally active, competitive, potent, selective JAK1 inhibitor, with an IC50 of 9.8 nM, and 11-, 55- and 23-fold selectivity over JAK2, JAK3 and TYK2, respectively, Solcitinib is used in the research of moderate-to-severe plaque-type psoriasis.
Molecular Weight:
389.45
Purity:
99.51
CAS Number:
[1206163-45-2]
Formula:
C22H23N5O2
Target:
JAK
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
